Document:

EX-10.18.3

 Exhibit 10.18.3 

THE SECURITIES REPRESENTED BY THIS INSTRUMENT OR CERTIFICATE AND ANY SECURITIES ISSUABLE UPON ITS CONVERSION HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY
THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS. 
 HC2 HOLDINGS, INC. 

OPTION TO PURCHASE SHARES OF COMMON STOCK 
 (CONTINGENT OPTION) 
 Date of Issuance:
                , 2014 

[                ] Shares 

For value received, the receipt and sufficiency of which is hereby acknowledged, this Option (this “Option”) is issued
to Philip Falcone (the “Holder”), by HC2 Holdings, Inc., a Delaware corporation (together with any successor thereto, the “Company”). This Option is issued pursuant to the terms of that certain Option agreement,
dated as of May 12, 2014 (as reformed and clarified as of September     , 2014) (the “Master Option”), between the Company and the Holder, and entitles the Holder to subscribe for and purchase from the
Company, at the Exercise Price, the number of Exercise Shares of the Common Stock of the Company, subject to vesting and exercisability as provided herein. Capitalized terms used herein and not otherwise defined shall have the meanings given to them
in the Master Option. 
 The Exercise Shares are being issued to the Holder pursuant to Section 9 of the Master Option as a
result of the Company’s grant of Rights consisting of [options to subscribe for and purchase from the Company an aggregate of                  shares of the
Company’s Common Stock] [[restricted stock units] [shares of [Series A-1] [Series A] Preferred Stock ] ] convertible into an aggregate of                  shares of
the Company’s Common Stock] which grant constitutes an “Adjustment Event” under Section 9 of the Master Option. The Exercise Shares being issued pursuant to this Option constitute “Contingent Options” within the meaning
of Section 9 of the Master Option. 

 1. Definitions. As used herein, the following terms shall have the
following respective meanings: 
 (a) “Affiliate” of any specified Person means any other Person, directly or
indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any Person means the power to direct the management
and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

 (b) “Board” means the Board of Directors of the Company. 

(c) “Business Day” means any day, except a Saturday, Sunday or other day on which commercial banks in New York, New
York are authorized or obligated to close. 
 (d) “Capital Stock” shall mean, with respect to any Person, any
and all shares, interests, participations or other equivalents (however designated) of such Person’s capital stock or partnership, limited liability company or other equity interests at any time outstanding, and any and all rights, warrants or
options exchangeable for or convertible or exercisable into such capital stock or other interests, including any Preferred Stock. 
 (e) “Common Stock” means the common stock, par value $0.001 per share, of the Company, and any other Capital Stock into which the Common Stock shall have been converted, exchanged or
reclassified following the date and that is issuable pursuant to the terms hereof. 
 (f) “Exchange Act” means
the Securities Exchange Act of 1934, as amended. 
 (g) “Excluded Issuance” shall mean any of the following:
(i) the issuance of any shares of Common Stock or Rights pursuant to any employee benefit plan or program, incentive compensation plan or program, executive compensation agreement or directors’ compensation program, in each case approved
by the Board or a committee thereof, or pursuant to this Option, (ii) the issuance of any shares of Common Stock upon exercise of any of the Class A Options and/or Class B Options of the Company outstanding as of the date of this Option,
and (iii) the issuance of any shares of Common Stock or Rights pursuant to a Fundamental Change Transaction. 
 (h)
“Exercise Price” means $[        ] per share, subject to adjustment pursuant to Section 9. 
 (i) “Exercise Shares” means the shares of Common Stock issuable upon exercise of this Option, in an original amount of up to
                 shares of the Company’s Common Stock, subject to vesting and exercisability restrictions and adjustment pursuant to the terms herein, including but
not limited to adjustment pursuant to Section 9 below. 

  
 -2-

 (j) “Fair Market Value” means, with respect to the Common Stock or any
other security or property as of any date of determination, the fair market value thereof as determined in good faith by the Company, in accordance with the following rules: 
 (i) for Common Stock or any other security listed or admitted to trading on a national securities exchange for at least ten (10) consecutive Trading Days immediately preceding such date of
determination, the Fair Market Value will be the volume-weighted average price of such security for the ten (10) consecutive Trading Days immediately preceding such date of determination as reported by Bloomberg, L.P.; 

(ii) for any security that is not listed or admitted to trading on any national securities exchange for at least ten
(10) consecutive Trading Days immediately preceding such date of determination or the Fair Market Value of which cannot be determined in accordance with clause (i) above, the Fair Market Value of such security shall be its fair market
value as of such date of determination as reasonably determined by the Board in good faith on the basis of such information as it considers appropriate; or 
 (iii) for any other property, the Fair Market Value shall be as reasonably determined by the Board in good faith on the basis of such information as it considers appropriate, including an estimation of
the fair market value of such property assuming a willing buyer and a willing seller in an arms’-length transaction. 

(k) “Fundamental Change Transaction” means the occurrence of any of the following: (i) any Person or group of
related Persons for purposes of Section 13(d) of the Exchange Act (a “Group”), other than one or more Principal Stockholders, has, directly or indirectly, become the “beneficial owner” (as defined in Rules 13d-3 and
13d-5 under the Exchange Act) of more than 50% of the total voting power of all shares of Capital Stock of the Company that are entitled to vote generally in the election of directors; (ii) any merger, consolidation, stock or asset purchase,
recapitalization or other business combination transaction (or series of related transactions) as a result of which any Person or Group, other than one or more Principal Stockholders, is or becomes the “beneficial owner” (as defined above)
of more than 50% of the total voting power of all shares of Capital Stock that are entitled to vote generally in the election of directors of the entity surviving or resulting from such transaction (and, if such surviving or resulting entity is a
subsidiary of a parent Person, the ultimate parent thereof); (iii) the sale, transfer or disposition, including but not limited to any spin-off or in-kind distribution, of all or substantially all of the assets of the Company (on a consolidated
basis) to any Person or Group (other than the Company or one or more of its wholly-owned subsidiaries or one or more Principal Stockholders), or (iv) the dissolution, liquidation or winding up of the Company. 

(l) “Harbinger Persons” means, collectively, Philip Falcone, Harbinger Group Inc., HGI Funding, LLC, Harbinger Capital
Partners Master Fund I, Ltd., Harbinger Capital Partners LLC, Harbinger Holdings, LLC, Harbinger Capital Partners Special Situations Fund, L.P., Harbinger Capital Partners Special Situations GP, LLC, Global Opportunities Breakaway Ltd. and Harbinger
Capital Partners II LP. 

  
 -3-

 (m) “Person” means any individual, corporation, partnership, joint
venture, association, joint-stock company, limited liability company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

(n) “Piggyback Registration” means a proposed registration by the Company of any shares of its securities under the Act
(other than a registration effected solely to implement an employee benefit plan or a transaction to which Rule 145 of the Act is applicable, or pursuant to a Registration Statement on Form S-4, S-8 or any successor form thereto or another form not
available for registering the issued or issuable Exercise Shares for sale to the public), whether for its own account or for the account of one or more stockholders of the Company, and the form of registration statement to be used may be used for
any registration of issued or issuable Exercise Shares. 
 (o) “Preferred Stock” as applied to the Capital
Stock of any corporation means Capital Stock of any class or classes (however designated) that by its terms is preferred as to the payment of dividends, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution
of such corporation, over shares of Capital Stock of any other class of such corporation. 
 (p) “Principal
Stockholders” means (i) any of the Harbinger Persons and their respective Affiliates, (ii) any investment fund or vehicle managed, sponsored or advised by any of the Harbinger Persons or any Affiliate thereof, and any Affiliate of
or successor to any such investment fund or vehicle; and (iii) any limited or general partners of, or other investors in, any of the Harbinger Persons or any Affiliate thereof, or any such investment fund or vehicle. 

(q) “Trading Day” means (i) if the Common Stock is traded on a national securities exchange, a day on which the
Common Stock is traded on the principal securities exchange on which the Common Stock is then listed or admitted to trading, or (ii) if the Common Stock is not listed on a national securities exchange, a Business Day. 

2. Purchase of Shares. 
 (a) Exercise Shares and Exercise Price. Subject to the terms and conditions set forth herein, including the vesting schedule for the Option set forth in Section 2(b), the Holder shall
be entitled, at any time and from time to time, to exercise this Option in whole or in part to purchase Exercise Shares at the Exercise Price; provided, however, that if and to the extent it is determined that any Consent is required
in connection with the exercise of this Option, in whole or in part, pursuant to Section 6(b) hereof, this Option (or portion thereof that is the subject of such required Consent) shall be unexercisable pending the making or delivery of
such Consent in accordance with Section 6(b). The term “Option” as used herein shall be deemed to include any options issued upon transfer or partial exercise of this Option unless the context clearly requires otherwise.

 (b) Vesting of Exercise Shares. Except as otherwise provided in Section 9(b) with respect to accelerated
vesting of unvested tranches of this Option in connection with a Fundamental Change Transaction, this Option shall become vested in three (3) equal 

  
 -4-

 
installments on each of (i) the issuance date set forth above and (ii) the first and second anniversaries of the issuance date set forth above, subject in the case of clause
(ii) above to the continuous employment of the Holder with the Company as of the applicable vesting date. 
 3.
Exercise. 
 (a) Exercise Period. This Option shall be exercisable, in whole or in part but subject to the
vesting and exercisability conditions set forth herein, during the term commencing on the date of issuance set forth above and ending on May 11, 2024, after which date it shall be null and void. 

(b) Exercise Requirements. The Exercise Shares shall become exercisable in accordance with and subject to
Section 2(a) with respect to the Exercise Shares on the later of (x) the date upon which the Exercise Shares vest pursuant to Section 2(b) and (y) the date that the Rights have resulted in the issuance of additional
shares of Common Stock as the result of exercise, conversion, exchange or otherwise in accordance with the terms applicable to such Rights (each such issuance of shares of Common Stock pursuant to Rights is referred to herein as a “Rights
Shares Issuance”) and then only in the same proportion as the proportion of the shares issued on the Rights Shares Issuance date bear to the total number of shares issuable upon the exercise of the related Rights. 

4. Method of Exercise. 
 (a) Vested and exercisable rights represented by this Option may be exercised during the exercise period set forth in Section 3(a) by: 

(i) the delivery to the Company of a duly executed copy of the Notice of Exercise attached hereto, directed to the attention of the
Secretary of the Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and 
 (ii) except in connection with a Net Exercise (as defined below) pursuant to Section 5, the payment to the Company by wire transfer to an account designated by the Company of an amount equal
to the aggregate Exercise Price for the number of Exercise Shares being purchased. 
 (b) Each exercise, in whole or in part,
of this Option shall be deemed to have been effected immediately prior to the close of business on the day on which this Option is exercised as provided in Section 4(a). At such time, the Person or Persons in whose name or names any
certificate for the Exercise Shares shall be issuable upon such exercise as provided in Section 4(c) shall be deemed to have become the holder or holders of record of the Exercise Shares represented by such certificate. 

  
 -5-

 (c) As soon as reasonably practicable after the exercise of this Option, in whole or in
part, the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as the Holder may direct: 
 (i) a certificate or certificates (with appropriate restrictive legends) for the number of Exercise Shares to which the Holder shall be entitled in such denominations as may be requested by the Holder;
and 
 (ii) in case such exercise is in part only, a new option or options of like tenor, for the aggregate number of Exercise
Shares equal to the number of Exercise Shares described in this Option minus the number of such Exercise Shares purchased by the Holder upon all exercises made in accordance with Section 4(a) or Section 5. 

(d) Notwithstanding any other provisions hereof, if an exercise of any portion of this Option is to be made in connection with the
consummation of a Piggyback Registration or a Fundamental Change Transaction, the exercise of any portion of this Option may, at the election of the Holder hereof, be conditioned upon the consummation of the Public Offering or Fundamental Change
Transaction, in which case such exercise shall not be deemed to be effective until immediately prior to the consummation of such transaction. 
 (e) Exercised Exercise Shares shall be deducted from the earliest vesting tranches of this Option, to the extent available. 
 5. Net Exercise. In lieu of exercising this Option for cash, the Holder may elect to receive, without the payment by the Holder of any additional consideration, Common Stock
equal to the value of this Option (or the portion thereof being exercised) (a “Net Exercise”). Upon a Net Exercise, the Holder shall have the rights described in Sections 4(b) and 4(c), and the Company shall issue to
the Holder a number of shares of Common Stock computed using the following formula: 
  

					
	X =	 	
 Y (A - B)
	  	
	 	A	  	

 Where: 

 

			
	X =	  	The number of shares of Common Stock to be issued to the Holder.
		
	Y =	  	The number of Exercise Shares purchasable under this Option or, if only a portion of the Option is being exercised, the portion of the Option being exercised (at the date of such
calculation).
		
	A =	  	The Fair Market Value of one (1) share of Common Stock (at the date of such calculation).
		
	B =	  	The Exercise Price (as adjusted to the date of such calculation).

 6. Regulatory Requirements. 

(a) Hart-Scott-Rodino. If any filing or notification becomes necessary pursuant to the Hart-Scott-Rodino Antitrust Improvements
Act of 1976, as amended (the “HSR Act”), based upon the planned exercise of this Option or any portion hereof, the Holder shall notify the Company of such requirement, and the Holder and the Company shall file with the

  
 -6-

 
proper authorities all forms and other documents necessary to be filed pursuant to the HSR Act as promptly as possible and shall cooperate with each other in promptly producing such additional
information as those authorities may reasonably require to allow early termination of the notice period provided by the HSR Act or as otherwise necessary to comply with requirements of the Federal Trade Commission or the Department of Justice. The
Holder and the Company agree to cooperate with each other in connection with such filings and notifications, and to keep each other informed of the status of the proceedings and communications with the relevant authorities. 

(b) Other Regulatory Requirements. If the Holder or the Company determines that the exercise of this Option would require prior
notice to, a filing with, or the consent, approval or order by, the Federal Communications Commission or any other federal, state or local regulatory agency or other governmental entity that is vested with jurisdiction over the Company (each, a
“Consent”), the Holder and the Company shall have made or received all necessary Consents, to the reasonable satisfaction of both parties, prior to effecting the exercise of this Option. 

7. Representations, Warranties and Covenants of the Company. In connection with the transactions provided for
herein, the Company hereby represents and warrants and covenants and agrees, as applicable, to the Holder that: 
 (a)
Organization; Authority. The Company is duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with the requisite corporate power and authority to own and use its properties and assets and to carry
on its business and to execute and deliver this Option and to consummate the transactions contemplated hereby. The Company is not in violation of, nor will the consummation of the transactions contemplated by this Option violate, any provisions of
the certificate of incorporation or by-laws of the Company. 
 (b) Authorization; Enforceability. The execution and
delivery of this Option by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company and no further consent or action with respect thereto is required
by the Company or its Board or stockholders. This Option has been duly executed and delivered by the Company and is a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such
enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies. 
 (c) Valid Issuance of Common Stock. The Common Stock of the Company issuable upon exercise of
this Option has been duly authorized and when issued upon exercise in accordance with this Option will be validly issued, fully paid and nonassessable. None of the Common Stock of the Company issuable upon exercise of this Option will be issued in
violation of any preemptive or other similar rights of any securityholder of the Company. 
 (d) Reservation of Shares.
The Company covenants and agrees that during the period within which the rights represented by this Option may be exercised, the 

  
 -7-

 
Company will at all times have authorized and reserved, for the purpose of issue or transfer upon exercise of this Option, a sufficient number of shares of authorized but unissued Common Stock of
the Company, when and as required to provide for the exercise of the rights represented by this Option. The Company will take all such action as may be necessary to assure that such Common Stock may be validly issued as provided herein without
violation of any applicable law or regulation. 
 (e) Piggyback Registration. Whenever the Company proposes to register
any shares of its securities by means of a Piggyback Registration, the Company shall give prompt written notice (in any event no later than thirty (30) days prior to the filing of the applicable registration statement) to the Holder of its
intention to effect such a Piggyback Registration and will, subject to customary provisions for the priority of registered securities, afford such Holder the opportunity to include its registrable and issued or issuable Exercise Shares in the
registration statement, to the extent the Holder has provided to the Company a written request (the “Registration Election”) for inclusion of such registrable Exercise Shares within fifteen (15) days after the Company’s
notice has been given to the Holder, as well as a duly executed copy of a Notice of Exercise with respect to any Exercise Shares issuable upon exercise of this Option to be included in the applicable Piggyback Registration, specifying the number of
such Exercise Shares to be so included. The Company may postpone or withdraw the filing or the effectiveness of a Piggyback Registration at any time in its sole discretion. 
 8. Representations and Warranties of the Holder. In connection with the transactions provided for herein, the Holder hereby represents and warrants to the Company that: 

(a) Authority. The Holder has the requisite legal capacity and authority to execute and deliver this Option and to consummate the
transactions contemplated hereby. 
 (b) Enforceability. This Option has been duly executed and delivered by the Holder
and is a valid and binding obligation of the Holder, enforceable against the Holder in accordance with its terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. 
 (c) Investment Intent. The Holder is a financially sophisticated institutional investor and is an “accredited investor” (as defined in Rule 501 of Regulation D under the Act) that is
experienced in financial matters and is acquiring this Option and any Exercise Shares issuable upon exercise of this Option for his own account for investment and with no present intention of, or view to, distributing this Option or any Exercise
Shares issuable upon exercise of this Option except in compliance with the Act, but without prejudice to the Holder’s right at all times to sell or otherwise dispose of all or any part of this Option or any Exercise Shares issuable upon
exercise of this Option under a registration statement filed under the Act, or in a transaction exempt from the registration requirements of the Act, including a transaction pursuant to Rule 144 under the Act. 

  
 -8-

 (d) Legends. The Holder acknowledges that, to the extent applicable, each
certificate evidencing Exercise Shares issued upon exercise of this Option shall be endorsed with the legend substantially in the form set forth below, as well as any additional legend imposed or required by applicable state securities laws:

 THE SECURITIES REPRESENTED BY THIS INSTRUMENT OR CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY HC2 HOLDINGS, INC., OR ANY SUCCESSOR THERETO (THE “COMPANY”), UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR SUCH LAWS. 
 9. Adjustment of Exercise
Price and Number of Exercise Shares. The Exercise Price of this Option and the number of Exercise Shares issuable upon the exercise of this Option shall be adjusted from time to time as set forth in this Section 9, and which
adjustment may be in the form of the issuance of a new option, which new option shall be subject to substantially the same terms as this Option, but with the modifications provided for in this Section 9. 

(a) Corporate Transactions. In case (i) the Company shall hereafter pay a dividend or make a distribution to all holders of
the outstanding Common Stock in shares of Common Stock, (ii) the outstanding shares of Common Stock shall be subdivided into a greater number of shares of Common Stock, or combined into a smaller number of shares of Common Stock, (iii) the
Company shall, by dividend or otherwise, distribute to all holders of Common Stock shares of any class of Capital Stock of the Company, debt securities, assets or other property of the Company, (iv) the Company shall make an extraordinary cash
dividend to all holders of Common Stock or (v) the Company shall engage in any other transaction that would constitute a corporate transaction within the meaning of Section 424 of the Internal Revenue Code of 1986, as amended, or any
successor statute thereto (“Code Section 424”), the number of shares of Common Stock to be received by the Holder and the Exercise Price payable upon exercise of this Option shall be appropriately adjusted in a manner that
would satisfy the requirements of Code Section 424 (without regard to the requirement that an eligible corporation be the employer of the optionee) if the Option were a statutory stock option. 

(b) Fundamental Change Transaction. If, at any time while any portion of this Option is outstanding there occurs a Fundamental
Change Transaction, then (i) as of immediately prior to the occurrence of such Fundamental Change Transaction, this Option shall be deemed fully vested, and (ii) the Holder, from and after the occurrence of such Fundamental Change
Transaction, shall have the right upon exercise of all or any portion of this Option (and payment of the applicable Exercise Price) to receive (but only out of legally 

  
 -9-

 
available funds, to the extent required by applicable law) the kind and amount of stock, other securities, cash and/or assets (the “Alternate Consideration”) that the Holder
would have received if this Option (or portion thereof being exercised) had been exercised pursuant to the terms hereof immediately prior to such Fundamental Change Transaction (assuming for this purpose that the Holder did not exercise any
applicable rights of election, if any, as to the kind or amount of stock, securities, cash, assets or other property receivable upon such Fundamental Change Transaction). For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Change Transaction, and the Company shall apportion the
Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration, but in all events in accordance with the requirements of Code Section 424. Any
successor to the Company or surviving Person in such Fundamental Change Transaction shall issue to the Holder a new option substantially in the form of this Option and consistent with the foregoing provisions and evidencing the Holder’s right
to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof and, upon such issuance, this Option shall be automatically cancelled and shall cease to be of further force or effect. The terms of any agreement
pursuant to which a Fundamental Change Transaction is effected shall include terms requiring any such successor or surviving Person to comply with the foregoing provisions. 
 (c) Calculations. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company. No adjustment need be made for:

 (i) any Excluded Issuances; 
 (ii) a change in the par value of the Common Stock; or 
 (iii) any event for
which an adjustment has already been provided under any subsection of this Section 9; provided, however, that if any event occurs that would result in an adjustment under more than one subsection of this
Section 9, the subsection that results in the most favorable adjustment to the Holder shall control. 
 To the extent this Option
becomes exercisable into cash, no adjustment need be made thereafter as to the cash. Interest will not accrue on the cash. Any adjustments to the number of Exercise Shares hereunder shall be apportioned among the three vesting tranches of the Option
as nearly equal as possible. 
 (d) Form of Option After Adjustment. Except as otherwise provided in
Section 9(b), the form of this Option need not be changed because of any adjustments in the Exercise Price or the number of Exercise Shares issuable upon exercise of this Option, and Options theretofore or thereafter issued may continue
to express the same price and number and kind of shares as are stated in this Option, as initially issued. 

  
 -10-

 10. No Fractional Shares. No fractional shares of Common Stock shall be issued
in connection with any exercise hereunder, but in lieu of such fractional shares the Company shall, at its sole option, (a) round up such fraction to the nearest whole number of shares of Common Stock or (b) make a cash payment
therefor based on the Fair Market Value thereof. 
 11. Notices to Holder. Upon any adjustment of the number of
Exercise Shares issuable upon exercise of this Option or the Exercise Price of this Option, including any adjustment pursuant to Section 9, the Company, within twenty (20) calendar days thereafter, shall prepare and deliver, or
cause to be prepared and delivered, to the Holder a certificate signed by an officer setting forth the event giving rise to such adjustment, such Exercise Price and the number of Exercise Shares (as divided into each vesting tranche of the Option)
after such adjustment and setting forth in reasonable detail the method of calculation and the facts upon which such adjustment was made, which certificate shall be conclusive evidence of the correctness of the matters set forth therein. Where
appropriate, such notice may be given in advance and included as a part of the notice required to be mailed under the other provisions of this Section 11. In the event of: 

(a) a Rights Shares Issuance; or 
 (b) any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, or
any right to subscribe for, purchase or otherwise acquire any shares of Capital Stock of any class or any other securities or property, or to receive any other right; or 
 (c) any Fundamental Change Transaction; 
 then, and in each such event, the Company shall cause
written notice to be provided to the Holder of, respectively, (i) the date on which any such Rights Share Issuance is to occur and the number of Rights the applicable Rights holder(s) intends to exercise, convert or exchange and the total
number of shares issuable upon the exercise of the related Rights, (ii) the date on which any such record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend,
distribution or right, and (iii) the date on which any such Fundamental Change Transaction is anticipated to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or other securities) shall be
entitled to exchange their shares of Common Stock (or other securities) for securities or other property deliverable on such Fundamental Change Transaction. Such notice shall be delivered by the Company as set forth above as soon as reasonably
practicable prior to the date specified in such notice on which any such action is to be taken; provided, however, that in no event shall the Company be required to deliver such notice (x) more than ten (10) Business Days
prior to such specified date or (y) prior to the time the Company publicly discloses or is required by law (if required by law) to publicly disclose such event. Failure to give such notice shall not affect the validity of any action taken in
connection therewith. 
 12. No Stockholder Rights. Prior to exercise of this Option, the Holder shall not be
entitled to any rights of a stockholder with respect to the Exercise Shares, including (without limitation) the right to vote such Exercise Shares, receive dividends or other 

  
 -11-

 
distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in this Option, such Holder shall not be entitled to any stockholder
notice or other communication concerning the business or affairs of the Company. 
 13. Transfer of Vested Portions of
Option. Subject to compliance with applicable federal and state securities laws and any other contractual restrictions between the Company and the Holder contained herein, vested portions of this Option and all rights hereunder with respect
thereto are transferable, in whole or in part, by the Holder upon prior written consent of the Company, not to be unreasonably withheld, conditioned or delayed, and upon receipt of an assignment agreement in form and substance satisfactory to the
Company, pursuant to which the transferee will agree to be bound by the terms and conditions of this Option. Any such transfer shall be recorded on the books of the Company upon the surrender of this Option, properly endorsed, to the Company at its
principal offices, and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. In the event of a partial transfer, the Company shall issue to the new holders one or more appropriate new options.

 14. Governing Law. This Option shall be governed by and construed in accordance with the laws of the State of
New York, without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of New York.

 15. Submission to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this
Option or the transactions contemplated hereby may be instituted in the federal courts of the United States of America or the courts of the State of New York in each case located in the city of New York, and each party irrevocably submits to the
exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified or registered mail to such party’s address set forth herein shall be effective service of process
for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to
plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. 
 16. Waiver of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Option is likely to involve complicated and difficult issues and,
therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Option or the transactions contemplated hereby. 

17. Successors and Assigns. The terms and provisions of this Option shall inure to the benefit of, and be binding upon, the
Company and the Holder and their respective successors and permitted assigns. This Option shall be binding upon any Person succeeding the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets.

  
 -12-

 18. Headings. Headings and subheadings in this Option are for convenience and
identification only and are in no way intended to describe, interpret, define or limit the scope, extent or intent of this Option or any provision hereof. 
 19. Notices. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be delivered personally, by commercial overnight courier, or by
facsimile, directed to the addresses set forth below. Notices and other communications are deemed properly given as follows: (a) if delivered personally, on the date delivered, (b) if delivered by a commercial overnight courier, one
(1) Business Day after such notice is sent, and (c) if delivered by facsimile, on the date of transmission, with confirmation of transmission. 
 If to the Company, at: 
 HC2 Holdings, Inc. 

460 Herndon Parkway, Suite 150 
 Herndon, VA 20170 
 Attn: Andrea Mancuso, Acting General Counsel 

Fax: (703) 650-4295 
 If to the Holder, at: 
 Philip Falcone 

450 Park Avenue, 30th Floor 
 New York, NY 10022 
 Fax: 212-339-5101 

or at such other address as may be substituted by notice given as herein provided. 

20. Entire Agreement; Amendments and Waivers. This Option and the documents delivered pursuant hereto constitute the
entire agreement, and supersede all other prior agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof. Any provision of this Option may be amended or waived if, and only if, such
amendment or waiver is in writing and signed. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver. No failure or delay on the part of any party
in exercising any right, power or remedy hereunder shall operate as a suspension or waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any
other right, power or remedy hereunder. 
 21. Severability. Any term or provision of this Option which is
invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Option in any
other jurisdiction. If any provision of this Option is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable. 

  
 -13-

 22. Issue Tax. The issuance of certificates for Exercise Shares upon
the exercise of this Option shall be made without charge to the Holder of this Option for any issue tax in respect thereof; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any
transfer involved in the issuance and delivery of any certificate in a name other than that of the then holder of this Option being exercised. 
 23. Third-Party Beneficiaries. Nothing in this Option shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or claim
under this Option, and this Option shall be for the sole and exclusive benefit of the Company and the Holder. 
 24.
Counterparts. This Option may be executed in any number of counterparts (including by facsimile or portable document format (PDF) signatures) and each of such counterparts shall for all purposes be deemed to be an original, and such
counterparts shall together constitute but one and the same instrument. 
 25. Headings. The headings of
sections of this Option have been inserted for convenience of reference only, are not to be considered a part hereof and in no way modify or restrict any of the terms or provisions hereof. 

26. Remedies. Each party stipulates that the remedies at law of the other party in the event of any default or
threatened default in the performance of or compliance with any of the terms of this Option are not and will not be adequate, and that such terms may be specifically enforced by a decree for the specific performance of any agreement contained herein
or by an injunction against a violation of any terms hereof or otherwise. The remedies herein provided are in addition to and not exclusive of any other remedies provided at law or in equity. 

[Signature appears on next page] 

  
 -14-

 IN WITNESS WHEREOF, the parties hereto have caused this Option to be executed as of the date
first set forth above. 
  

			
	HC2 HOLDINGS, INC.
		
	By:	 	  

	Name:	 	Andrea L. Mancuso
	Title:	 	Acting General Counsel
	
	PHILIP FALCONE
	
	  

 Signature Page to Option 

 NOTICE OF EXERCISE 
 HC2 HOLDINGS, INC. 
 (1) The undersigned hereby elects to (check one box
only): 
  ̈ purchase
                 shares of the Common Stock (as defined in the Option) of HC2 Holdings, Inc. (together with any successor thereto, the “Company”)
pursuant to the terms of the Option, dated as of October     , 2014 (the “Option”), between the Company and the Holder (as defined therein) thereof, and tenders herewith payment of the Exercise Price (as
defined in the Option) in full for such Exercise Shares (as defined in the Option), together with any applicable transfer taxes with respect thereto. 
  ̈ purchase the number of shares of Common Stock of the Company by Net Exercise (as defined in the Option) pursuant to the terms of the Option as shall be
issuable upon Net Exercise of the portion of the Option relating to                  Exercise Shares. 

(2) Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such
other name as is specified below: 
  

	
	  

	(Name)
	
	  

	(Address)

  

									
		 		 		 	HOLDER:
					
	Date:	 	  
	 		 	By:	 	  

		 		 		 	Name:	 	
		 		 		 	Title:EX-10.7.12

 Exhibit 10.7.12 

DIRECTOR RESTRICTED PHANTOM UNIT AGREEMENT 

UNDER 
 THE STONEMOR
PARTNERS L.P. 2014 LONG-TERM INCENTIVE PLAN 
 This Director Restricted Phantom Unit Agreement (the “Agreement”) entered into
as of November 11, 2014 (the “Agreement Date”), by and between StoneMor GP LLC (the “Company”), the general partner of and acting on behalf of StoneMor Partners L.P., a Delaware limited partnership (the
“Partnership”) and                             , a director of the Company (the
“Participant”). 
 BACKGROUND: 

In order to make certain awards to key employees, directors and consultants of the Company and its Affiliates, the Company maintains the
StoneMor Partners L.P. 2014 Long-Term Incentive Plan, subject to the unitholders approval as required by the listing rules of the New York Stock Exchange (the “Plan”). The Plan is administered by the Compensation, Nominating and
Governance, and Compliance Committee (the “Committee”) of the Board of Directors of the Company. The Committee has determined to grant to the Participant, pursuant to the terms and conditions of the Plan, an award (the “Award”)
of Phantom Units, representing notional limited partner interests in StoneMor Partners L.P. (the “Partnership”). The Participant has determined to accept such Award. Any initially capitalized terms and phrases used in this Agreement, but
not otherwise defined herein, shall have the respective meanings ascribed to them in the Plan. 
 This document is intended to formalize a
prior agreement made with the Participant in connection with the Participant’s service as a Director of the Company. 
 NOW, THEREFORE,
the Company and the Participant, each intending to be legally bound hereby, agree as follows: 
 ARTICLE I 

AWARD OF PHANTOM UNITS 

1.1 Creation of Mandatory Deferred Compensation Account. Commencing with the meeting of the Board of Directors of the Company on
November 11, 2014, compensation in the annual amount of $            (“Annual Deferral”) payable to the Participant in consideration for service as a Director shall be
deferred and credited, in the form of Phantom Units, to a mandatory deferred compensation account (the “Mandatory Deferred Compensation Account”) established by the Company for the Participant. 

1.2 Crediting Phantom Units. The Annual Deferral shall be credited in four (4) equal quarterly installments to the
Participant’s Mandatory Deferred Compensation Account in the form of Phantom Units, each installment to be credited on the date of the regular quarterly meeting of the Board for such quarter. The number of Phantom Units (or fractions thereof)
to be credited to the Participant’s Mandatory Deferred Compensation Account shall be determined by dividing the amount of each quarterly installment by the closing price for common units (“Common Units”) of the Partnership as
published in The Wall Street Journal or in Yahoo  

 
Finance for the trading day immediately prior to the first day of such regular quarterly Board meeting. Notwithstanding the foregoing, in the event that there is no meeting of the Board
during any calendar quarter, the crediting shall occur on such date as is designated by the Company. Crediting of Phantom Units (or fractions thereof) to the Participant’s Mandatory Deferred Compensation Account shall not entitle the
Participant to the rights of a limited partner of the Partnership or a holder of Units. The term “quarterly”, as used in this Agreement, refers to calendar quarters. 

1.3 Crediting Distribution Equivalent Rights (“DERs”). For each Phantom Unit in the Participant’s Mandatory Deferred
Compensation Account, the Company shall credit such account, solely in Phantom Units (or fractions thereof), with an amount, in respect of DERs, equal to the cash distributions paid on a Unit. The crediting shall occur as of the date on which such
cash distributions on the Common Units of the Partnership are paid. The number of Phantom Units (or fractions thereof) to be credited to the Participant’s Mandatory Deferred Compensation Account shall be calculated by dividing the dollar amount
of the DERs by the closing price for the Common Units of the Partnership as published in The Wall Street Journal or in Yahoo Finance for the trading day immediately prior to the day on which the cash distribution is paid on the Units.
Any fractional Phantom Unit created by DERs or otherwise shall likewise be entitled to further DERs equal to cash distributions paid on Common Units of the Partnership multiplied by such fractional Phantom Unit. The Company will establish a
bookkeeping method to account for DERs to be credited to the Participant’s Mandatory Deferred Compensation Account. DERs shall cease to be credited to the Participant’s Mandatory Deferred Compensation Account from and after any of the
events specified in Section 1.4 hereof, except to the extent that any balance remains in the Participant’s Mandatory Deferred Compensation Account after such event. DERs shall not bear interest. 

1.4 Time of Payment. Participant shall be entitled to payment of the Participant’s Mandatory Deferred Compensation Account upon
the first payment event to occur pursuant to Section 409A(a)(2) of the Code and the rules and regulations adopted thereunder as follows: 

(1) Separation from Service as described under Section 409A of the Code and the rules and regulations adopted thereunder; or 

(2) Disability of the Participant. The Participant is considered disabled if he is unable to engage in any substantial gainful activity by
reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months; or 

(3) an “Unforeseeable Emergency” with respect to the Participant, but subject to the limitations under Section 409A of the Code
and the rules and regulations adopted thereunder as to any amount which may be paid. An Unforeseeable Emergency means a severe financial hardship to the Participant resulting from an illness or accident of the Participant, the Participant’s
spouse, the Participant’s dependent (as defined in Code section 152, without regard to section 152(b)(1), (b)(2), and (d)(1)(B)) or a Beneficiary; loss of the Participant’s property due to casualty (including the need to rebuild a home
following damage to a home not otherwise covered by insurance, for example, as a result of a natural disaster); or other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. The
types of events which may qualify as an Unforeseeable Emergency may be limited by the Committee; or 

  
 2 

 (4) a “Change of Control” of the Partnership or Company, as defined in the Plan, but
subject to any further limitations under Section 409A of the Code and the rules and regulations adopted thereunder; or 
 (5) death of
the Participant. Upon the death of a Participant prior to the full payment of all amounts credited to the Participant’s Mandatory Deferred Compensation Account, the balance of such Mandatory Deferred Compensation Account shall be paid in
accordance with Sections 1.5 and 1.6. 
 All payments of the Participant’s Mandatory Deferred Compensation Account will commence on or
before the later of: (1) the last day of the calendar year in which the payment event occurs or (2) the 15th day of the third month following the date the payment event occurs. No payment of the Mandatory Deferred Compensation Account
shall be made to the Participant prior to the occurrence of any of the preceding payment events and only to the extent permitted under Section 409A(a)(2) of the Code and the rules and regulations adopted thereunder. 

1.5 Method of Payment. 

(a) All payments for Phantom Units (or fractions thereof) credited to the Participant’s Mandatory Deferred Compensation Account shall be
made in Common Units of the Partnership, except as the Company, at its option, otherwise elects as provided in Section 1.5(b) hereof. The number of Common Units of the Partnership paid shall be equal to the number of whole Phantom Units in the
Participant’s Mandatory Deferred Compensation Account. For this purpose, any fractional Phantom Units in such Account shall be combined to equal whole Phantom Units to the extent possible. If after such combination there is any remaining
fractional Phantom Unit, such remaining fractional Phantom Unit shall be distributed as an amount of cash equal to the product of multiplying such fractional Phantom Unit by the closing price for Common Units of the Partnership as published in
The Wall Street Journal or in Yahoo Finance for the trading day immediately prior to the payment date. 
 (b) The Company, at
its option, may elect to pay all or any portion of the Mandatory Deferred Compensation Account in cash instead of paying in Common Units of the Partnership. Phantom Units (or fractions thereof) credited to the Participant’s Mandatory Deferred
Compensation Account shall be valued at the closing price for Common Units of the Partnership as published in The Wall Street Journal or in Yahoo Finance for the trading day immediately prior to the payment date. 

1.6 Designation of Beneficiary. 

(a) In the event of the Participant’s death, the primary death beneficiaries and contingent death beneficiaries entitled to receive
payments due the Participant at the time of death are designated below the Participant’s signature on this Agreement, unless such designation is amended as provided in this Section 1.6, in which case the amended designation shall apply. No
amendment to the designation of the beneficiaries shall be valid unless in a writing, signed by the Participant, dated, and filed with the Committee during the lifetime of the 

  
 3 

 
Participant. A subsequent beneficiary designation will cancel all beneficiary designations signed and filed earlier under this Agreement. In case of a failure of designation of a beneficiary, or
the death of the designated beneficiary (to whom a payment is otherwise due hereunder) without a designated successor, distribution shall be paid in one lump sum to the estate of the Participant. 

(b) The interest in any amounts hereunder of a spouse who has predeceased the Participant shall automatically pass to the Participant and
shall not be transferable by such spouse in any manner, including, but not limited to, such spouse’s will, nor shall such interest pass under the laws of intestate succession. 

(c) No payment shall be made to a designated contingent death beneficiary unless it is proven to the satisfaction of the Committee that the
designated primary death beneficiary is deceased. 
 1.7 Source of Payments. All payments of deferred compensation shall, if paid in
cash, be paid solely from the general funds of the Partnership and the Partnership and the Company shall be under no obligation to segregate any assets in connection with the maintenance of any Mandatory Deferred Compensation Account, nor shall
anything contained in this Agreement nor any action taken pursuant to the Plan create or be construed to create a trust of any kind, or a fiduciary relationship between the Partnership or the Company with the Participant. Title to the beneficial
ownership of any assets, whether cash or investments, that the Partnership or the Company may designate to pay the amount credited to a Mandatory Deferred Compensation Account shall at all times remain in the Partnership and the Participant shall
not have any property interest whatsoever in any specific assets of the Partnership or the Company. Participant’s interest in any Mandatory Deferred Compensation Account shall be limited to the right to receive payments pursuant to the terms of
this Agreement and such rights to receive shall be no greater than the right of any other unsecured general creditor of the Partnership. 

1.8 Nonalienation of Benefits. Participant shall not have the right to sell, assign, transfer or otherwise convey or encumber in whole
or in part the right to receive any payment under this Agreement except in accordance with Section 1.6, and the right to receive any payment hereunder shall not be subject to attachment, lien or other involuntary encumbrance. 

1.9 Acceptance of Terms. The terms and conditions of this Agreement shall be binding upon the heirs, beneficiaries and other successors
in interest of the Participant to the same extent that said terms and conditions are binding upon the Participant. 
 ARTICLE II 

GENERAL PROVISIONS 
 2.1
No Right Of Continued Board Service. The receipt of this Award does not give the Participant, and nothing in the Plan or in this Agreement shall confer upon the Participant, any right to continue in the service of the Board of the Company or
any of its subsidiaries. Nothing in the Plan or in this Agreement shall affect any right which the Company or any of its subsidiaries may have to terminate the Board service of the Participant. The payment of Mandatory Deferred Compensation Account
under this Agreement shall not give the Company or any of its subsidiaries any right to the continued services of the Participant for any period. 

  
 4 

 2.2 Rights As A Limited Partner. Neither the Participant nor any other person shall be
entitled to the privileges of ownership of Common Units of the Partnership, limited partnership interests in the Partnership, or otherwise have any rights as a limited partner, by reason of the award of the Phantom Units covered by this Agreement.

 2.3 Tax Withholding. All distributions under this Agreement are subject to withholding of all applicable taxes. Cash payments in
respect of any Phantom Units, and/or the related DERs, shall be made net of any applicable federal, state, or local withholding taxes. 

2.4 Administration. Pursuant to the Plan, the Committee is vested with conclusive authority to interpret and construe the Plan, to
adopt rules and regulations for carrying out the Plan, and to make determinations with respect to all matters relating to this Agreement, the Plan and awards made pursuant thereto. The authority to manage and control the operation and administration
of this Agreement shall be likewise vested in the Committee, and the Committee shall have all powers with respect to this Agreement as it has with respect to the Plan. Any interpretation of this Agreement by the Committee, and any decision made by
the Committee with respect to this Agreement, shall be final and binding. The Committee may refuse to issue Common Units as provided in Section 8(f) of the Plan and, without limiting the foregoing, may refuse to issue Common Units if, in its
sole discretion, the Committee determines that the issuance of such Common Units may violate federal or state securities laws, the listing rules of the New York Stock Exchange, or the Second Amended and Restated Agreement of Limited Partnership of
the Company. 
 2.5 Effect of Plan; Construction. The entire text of the Plan is expressly incorporated herein by this reference and
so forms a part of this Agreement. In the event of any inconsistency or discrepancy between the provisions of this Agreement and the terms and conditions of the Plan under which the Phantom Units are granted, the provisions of the Plan shall govern
and prevail. The Phantom Units, the related DERs and this Agreement are each subject in all respects to, and the Company and the Participant each hereby agree to be bound by, all of the terms and conditions of the Plan, as the same may have been
amended from time to time in accordance with its terms; provided, however, that no such amendment shall deprive the Participant, without the Participant’s consent, of any rights earned or otherwise due to the Participant hereunder. 

2.6 Amendment or Supplement. This Agreement shall not be amended or supplemented except by an instrument in writing executed by both
parties to this Agreement, without the consent of any other person, as of the effective date of such amendment or supplement. 
 2.7
Captions. The captions at the beginning of each of the numbered Sections and Articles herein are for reference purposes only and will have no legal force or effect. Such captions will not be considered a part of this Agreement for purposes of
interpreting, construing or applying this Agreement and will not define, limit, extend, explain or describe the scope or extent of this Agreement or any of its terms and conditions. 

2.8 Governing Law. 

  
 5 

 (a) THE VALIDITY, CONSTRUCTION, INTERPRETATION AND EFFECT OF THIS AGREEMENT SHALL EXCLUSIVELY BE
GOVERNED BY AND DETERMINED IN ACCORDANCE WITH THE LAW OF THE COMMONWEALTH OF PENNSYLVANIA (WITHOUT GIVING EFFECT TO THE CONFLICTS OF LAW PRINCIPLES THEREOF), EXCEPT TO THE EXTENT PREEMPTED BY FEDERAL LAW, WHICH SHALL GOVERN. 

(b) It is the intention of the Company and the Participant that this Agreement satisfy the requirements set forth in Section 409A of the
Internal Revenue Code of 1986 (as amended) (the “Code”) as are necessary to allow the deferral of federal income tax on the deferred compensation resulting from this Agreement and to avoid the constructive receipt of such deferred
compensation. In the event that this Agreement fails to satisfy any of the requirements necessary to avoid constructive receipt under Section 409A of the Code, this Agreement shall be deemed automatically amended as of the date hereof to
conform to such requirements. 
 2.9 Notices. All notices, requests and demands to or upon the respective parties hereto to be
effective shall be in writing, sent by facsimile, by overnight courier or by registered or certified mail, postage prepaid and return receipt requested. Notices to the Company shall be deemed to have been duly given or made upon actual receipt by
the Company. Such communications shall be addressed and directed to the parties listed below (except where this Agreement expressly provides that it be directed to another) as follows, or to such other address or recipient for a party as may be
hereafter notified by such party hereunder: 
  

			
	(a) if to the Partnership or Company:		StoneMor GP LLC
			311 Veterans Highway, Suite B
			Levittown PA 19056
			Attention:        President and Chief Executive Officer

 (b) if to the Participant: to the address for the Participant as it appears on the Company’s records.

 2.10 Severability. If any provision hereof is found by a court of competent jurisdiction to be prohibited or unenforceable, it
shall, as to such jurisdiction, be ineffective only to the extent of such prohibition or unenforceability, and such prohibition or unenforceability shall not invalidate the balance of such provision to the extent it is not prohibited or
unenforceable, nor invalidate the other provisions hereof. 
 2.11 Entire Agreement. This Agreement constitutes the entire
understanding and supersedes any and all other agreements, oral or written, between the parties hereto, in respect of the subject matter of this Agreement, and embodies the entire understanding of the parties with respect to the subject matter
hereof. 
 2.12 Acceptance of Terms. The terms and conditions of this Agreement shall be binding upon the estate, heirs,
beneficiaries and other successors in interest of the Participant to the same extent that said terms and conditions are binding upon the Participant. 

  
 6 

 2.13 Arbitration. Any dispute or disagreement between Participant and the Partnership with
respect to any portion of this Agreement or its validity, construction, meaning, performance, or Participant’s rights hereunder shall be settled by arbitration, conducted in Philadelphia, Pennsylvania, in accordance with the Commercial
Arbitration Rules of the American Arbitration Association or its successor, as amended from time to time. However, prior to submission to arbitration the Participant will attempt to resolve any disputes or disagreements with the Partnership over
this Agreement amicably and informally, in good faith, for a period not to exceed two weeks. Thereafter, the dispute or disagreement will be submitted to arbitration. At any time prior to a decision from the arbitrator(s) being rendered, the
Participant and the Partnership may resolve the dispute by settlement. The Participant and the Partnership shall equally share the costs charged by the American Arbitration Association or its successor, but the Participant and the Partnership shall
otherwise be solely responsible for their own respective counsel fees and expenses. The decision of the arbitrator(s) shall be made in writing, setting forth the award, the reasons for the decision and award and shall be binding and conclusive on
the Participant and the Partnership. Further, neither Participant nor the Partnership shall appeal any such award. Judgment of a court of competent jurisdiction may be entered upon the award and may be enforced as such in accordance with the
provisions of the award. 
 IN WITNESS WHEREOF, the parties hereto, intending to be legally bound hereby, have executed this Agreement as of
the day first above written. 
  

							
	STONEMOR PARTNERS L.P.
		
	 By:
		    StoneMor GP LLC
			
			     By:
		  

				
					 Name:
		  

				
					 Title:
		  

  
 7 

 The Participant hereby acknowledges receipt of a copy of the foregoing Restricted Phantom Unit
Agreement and the Plan, and having read them, hereby signifies his or her understanding of, and his or her agreement with, their terms and conditions. The Participant hereby accepts this Restricted Phantom Unit Agreement in full satisfaction of any
previous written or verbal promises made to him or her by the Partnership or the Company or any of its other Affiliates with respect to Restricted Unit or Phantom Unit grants or other grants under the Plan. 

 

					
	  
		(seal)		  

	(Signature of Participant)				(Date)
			
	  
				  

	Name of Primary Death Beneficiary				Relationship to Participant
			
	  
				  

	Name of Contingent Death Beneficiary				Relationship to Participant

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]